Akihide Yoshimi

23PUBLICATIONS
88CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Urban hydrologyEpigenetics (incl. genome methylation and epigenomics)Medical infection agents (incl. prions)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|Sep 13, 2026
Integrated Analysis of HER2 Expression and ERBB2 Alterations in Bladder Cancer.

|Sep 07, 2026
Splicing modulation as an emerging therapeutic strategy in cancer: molecular mechanisms, clinical development, and future perspectives.

|Jul 17, 2026
A ferroptosis-suppressive state drives resistance to bladder-preserving chemoradiotherapy in muscle-invasive bladder cancer.

|Jul 16, 2026
Norepinephrine-induced small GTPase RHOB mediates nocturnal intraocular pressure rise in mice.

|Feb 03, 2026
Advances in antisense oligonucleotide treatment for cancer.

Lu Zhu, Pariha Muhtar, Susumu Goyama

|Jan 02, 2026
Synergistic intragenic epigenetic deregulation by IDH2 and SRSF2 mutations causes mis-splicing of key transcriptional regulators.

Aristeidis G Telonis, Robert F Stanley, Emmalee R Adelman

Pageof 4

Frequent Collaborators

4 joint publications

Omar Abdel-Wahab

3 joint publications

Takuya Tsujino

3 joint publications

Alessandro Pastore

2 joint publications

Alexander Drilon